Articles Tagged With:
-
Opioid Overutilization Management Program Paves Way for Success
Healthcare organizations could learn a great deal about developing an opioid management program by following some of the best practices created as a result of the federal Medicare mandate for health plan sponsors.
-
Pain Management in Workers’ Comp Has Evolved to a Holistic Approach
Psychosocial aspects of chronic pain are much better understood today than a generation ago. What healthcare organizations now know is that each person’s pain after an injury or surgery is different.
-
Case Management’s Role in Curbing Opioid Epidemic Increases
Opioid addiction resulted in more than 33,000 U.S. overdose deaths in 2015, making drug overdose the No. 1 cause of accidental death in the nation. The overdose death rate has quadrupled since the 1990s, as have sales of prescription painkillers, according to the American Society of Addiction Medicine.
-
Medical Marijuana Inc. Moves Forward With Proof of Concept Study
Medical Marijuana Inc. announced it is working with an Israel-based contract research organization to begin a clinical proof of concept study with its cannabidiol and gabapentin chewing gum product to treat restless leg syndrome in patients.
-
Pregnant Pause: Time to Push ‘Play’ on Trials With Expectant Mothers
There are many obstacles to including pregnant women in research, and IRBs may understandably err on the side of caution when it comes to expectant mothers in clinical trials.
-
Gene Expert: IRBs Should Prepare for Somatic Cell Trials
With somatic gene cell editing already underway in some trials, IRBs should prepare to deal with protocols involving noninheritable genetic changes.
-
The Single IRB: One Board to Rule Them All
The National Institutes of Health recently delayed the effective date of its requirement to designate a single IRB in research involving multiple boards, but NIH officials have lost none of their enthusiasm for the idea.
-
Community Research Training Helps Subjects Become Investigators
A new social-behavioral research model IRBs might encounter is one in which researchers include people who also could be participants, or their guardians, for the same studies.
-
Finding the Best Role for Community Members: A Look at Two Strategies
IRB questions sometimes arise about the role and responsibility of community members/nonscientists on review boards. Should their — and other nonaffiliated members’ — contributions be limited? Do they have enough training to be primary or secondary reviewers?
-
Newest Oncology Studies Raise Ethical, Other Questions for IRBs
Clinical research — especially involving oncology trials — is evolving with the introduction of new therapies and therapeutic mechanisms. These raise new and sometimes challenging questions for IRBs reviewing the study protocols.